Related Experiment Video
Updated: Dec 9, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular Risk in Children: Focus on Pathophysiological Aspects
Simonetta Genovesi1,2, Gianfranco Parati1,2
1School of Medicine and Surgery, University of Milano - Bicocca, 20100 Milan, Italy.
Insights
Cardiovascular damage, including arterial stiffening, begins in childhood, driven by risk factors like obesity. Obesity promotes inflammation and endothelial dysfunction, accelerating atherosclerosis and cardiovascular disease progression from an early age.
Area of Science:
- Cardiovascular medicine
- Pediatric cardiology
- Metabolic syndrome
Background:
- Cardiovascular diseases (CVD) are a leading cause of death and disability globally.
- Arterial stiffening and atherosclerotic changes can begin in early childhood, not just adulthood.
- Obesity is increasingly recognized as a significant contributor to early cardiovascular damage.
Abstract:
Cardiovascular diseases are the leading cause of death, disability, and health care costs in industrialized countries. In general, cardiovascular diseases occur in adulthood, but cardiovascular damage, including stiffening of the arteries, begins very early. Already in the first decade of life, alterations that will favor the formation of atherosclerotic plaques may be present. Cardiovascular risk factors, associated with genetic predisposition, may trigger a sequence of pathophysiological changes which are associated with the progression of the atherosclerosis process. In this frame, the role of obesity has been increasingly emphasized. Different mechanisms linking obesity to cardiovascular disease have been postulated. Endothelial dysfunction and subclinical inflammation seem to be related to the worsening of cardiovascular risk factors in obese subjects and might have an essential role in the development of insulin resistance and the initiation and progression of atherosclerotic lesions. Excess weight, and in particular visceral adiposity, are associated with hypertrophy and hyperplasia of the adipocytes, increased secretion of adipokines and inflammatory cytokines and increase in serum uric acid levels. The list of obesity-related biomarkers associated with cardiovascular damage is rapidly expanding and their importance has already been described in children as well. Pathophysiological changes involved in determining early cardiovascular damage starting from childhood are discussed in this Special Issue.
Related Concept Videos
Coronary Artery Disease I: Introduction
Cardiovascular Drugs: Classification based on Therapeutic Indications
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Pathophysiology of Cardiac Performance
Pharmacokinetics in Pediatric Patients: Drug Distribution
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

